Clinical Trials Directory

Trials / Completed

CompletedNCT00492622

Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis

Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Patients With Heartburn Associated With Gastroparesis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Louisville · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the blood drug levels of two prescribed medications, immediate-release omeprazole 40 mg powder and delayed-release omeprazole 40 mg capsule to determine which drug is better absorbed in patients with a slow stomach emptying (gastroparesis). Delayed-release omeprazole has a protective coating to prevent the drug omeprazole from being neutralized by stomach acid. Immediate-release omeprazole has sodium bicarbonate (antacid) which neutralizes the stomach acid, eliminating the need for a protective coating. Immediate-release omeprazole suspension may have a more rapid pharmacokinetic profile and greater overall drug absorption in gastroparesis.

Detailed description

Hypothesis: Immediate-release omeprazole suspension may have a more rapid pharmacokinetic profile and greater overall drug absorption in gastroparesis. This will result in shorter time to maximal drug concentration, greater maximal concentration, and greater total area under the curve of the concentration vs. time plot. Primary Objective: To compare the pharmacokinetics of omeprazole between immediate-release suspension and delayed-release capsules in patients with heartburn associated with gastroparesis. Study design: randomized, open-labeled, crossover treatment for 7 days with 10-14 days washout. Pharmacokinetic studies will be performed after 7 days on study drug.

Conditions

Interventions

TypeNameDescription
DRUGImmediate-release omeprazoleImmediate-release omeprazole 40 mg qam for 7 days
DRUGDelayed-release omeprazoleDelayed-release omeprazole 40 mg qam for 7 days

Timeline

Start date
2007-06-01
Primary completion
2008-12-01
Completion
2008-12-01
First posted
2007-06-27
Last updated
2017-07-28
Results posted
2017-07-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00492622. Inclusion in this directory is not an endorsement.